Literature DB >> 26312526

Anticipated directives and living will for terminal patients: an integrative review.

Silvana Bastos Cogo1, Valéria Lerch Lunardi1.   

Abstract

OBJECTIVE: characterizing the national and international scientific literature about the advanced directives of living will as applied to the terminally ill patient.
METHOD: integrative review considering the articles published in Portal Capes, SciELO, LILACS, MEDLINE, Journal of Bioethics and Bioethikos, with the descriptors: Advanced directives, Wills regarding life and Advance Directives, Living Will and Terminally Ill, totaling 44 articles submitted to content analysis.
RESULTS: three categories emerged: Students and professionals facing the advance directives of living will: Perceptions, opinions and practices; Patient's receptivity to the Advance Directives of Living Will; The family facing the advance directives of living will.
CONCLUSION: the relevance of the topic became evident as a guarantee of respect for the dignity and autonomy of the patient, as well as to reduce ethical conflicts faced by families and health professionals facing care at the end of life.

Entities:  

Mesh:

Year:  2015        PMID: 26312526     DOI: 10.1590/0034-7167.2015680321i

Source DB:  PubMed          Journal:  Rev Bras Enferm        ISSN: 0034-7167


  2 in total

1.  A systematic scoping review on patients' perceptions of dignity.

Authors:  Keith Zi Yuan Chua; Elaine Li Ying Quah; Yun Xue Lim; Chloe Keyi Goh; Jieyu Lim; Darius Wei Jun Wan; Simone Meiqi Ong; Chi Sum Chong; Kennan Zhi Guang Yeo; Laura Shih Hui Goh; Ray Meng See; Alexia Sze Inn Lee; Yun Ting Ong; Min Chiam; Eng Koon Ong; Jamie Xuelian Zhou; Crystal Lim; Simon Yew Kuang Ong; Lalit Krishna
Journal:  BMC Palliat Care       Date:  2022-07-04       Impact factor: 3.113

2.  Are advance directives helpful for good end of life decision making: a cross sectional survey of health professionals.

Authors:  Eimantas Peicius; Aurelija Blazeviciene; Raimondas Kaminskas
Journal:  BMC Med Ethics       Date:  2017-06-05       Impact factor: 2.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.